Sign inGet started

Hindman James M.

Insider CIK 1617615 · ARAY Director · MLND Director · SNNA Director · UROV Director · AGN EVP, Finance & Bus. Dev., CFO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ARAY ACCURAY INC A Award deriv2025-11-282025-12-0256,603— $056,603SEC↗
ARAY ACCURAY INC M Exercise deriv2025-11-212025-11-2556,603— $00SEC↗
ARAY ACCURAY INC M Exercise2025-11-212025-11-2556,603— $0294,804SEC↗
ARAY ACCURAY INC A Award deriv2024-11-292024-12-0356,603— $056,603SEC↗
ARAY ACCURAY INC A Award2023-11-302023-12-0456,603— $0238,201SEC↗
ARAY ACCURAY INC A Award2022-11-302022-12-0759,055— $0181,598SEC↗
ARAY ACCURAY INC A Award2021-11-302021-12-0231,185$4.81 $150.0K122,543SEC↗
UROV Urovant Sciences Ltd. D To issuer deriv2021-03-292021-03-3161,000— $00SEC↗
UROV Urovant Sciences Ltd. D To issuer deriv2021-03-292021-03-3115,000— $00SEC↗
UROV Urovant Sciences Ltd. D To issuer2021-03-292021-03-319,000— $00SEC↗
ARAY ACCURAY INC A Award2020-11-302020-12-0233,632— $091,358SEC↗
UROV Urovant Sciences Ltd. A Award deriv2020-07-212020-07-2315,000— $015,000SEC↗
UROV Urovant Sciences Ltd. A Award2020-07-212020-07-239,000— $09,000SEC↗
MLND Millendo Therapeutics, Inc A Award deriv2020-06-222020-06-2312,000— $012,000SEC↗
UROV Urovant Sciences Ltd. A Award deriv2020-06-012020-06-0161,000— $061,000SEC↗
ARAY ACCURAY INC A Award2019-11-292019-12-0348,701— $057,726SEC↗
ARAY ACCURAY INC A Award2019-09-302019-12-039,025— $09,025SEC↗
MLND Millendo Therapeutics, Inc A Award deriv2019-06-202019-06-2112,000— $012,000SEC↗
SNNA Sienna Biopharmaceuticals, A Award deriv2019-05-302019-06-0325,000— $025,000SEC↗
MLND Millendo Therapeutics, Inc A Award deriv2019-01-152019-01-176,000— $06,000SEC↗
MLND Millendo Therapeutics, Inc A Award deriv2018-12-072018-12-113,720— $03,720SEC↗
MLND Millendo Therapeutics, Inc A Award deriv2018-12-072018-12-1117,509— $017,509SEC↗
SNNA Sienna Biopharmaceuticals, A Award deriv2018-08-012018-08-0320,000— $020,000SEC↗
AGN ALLERGAN INC D To issuer deriv2015-03-172015-03-1919,000— $00SEC↗
AGN ALLERGAN INC D To issuer deriv2015-03-172015-03-1911,274— $00SEC↗
AGN ALLERGAN INC D To issuer deriv2015-03-172015-03-1912,057— $00SEC↗
AGN ALLERGAN INC D To issuer deriv2015-03-172015-03-191,000— $00SEC↗
AGN ALLERGAN INC D To issuer deriv2015-03-172015-03-1914,000— $00SEC↗
AGN ALLERGAN INC D To issuer deriv2015-03-172015-03-1915,500— $00SEC↗
AGN ALLERGAN INC D To issuer deriv2015-03-172015-03-19511— $00SEC↗
AGN ALLERGAN INC D To issuer deriv2015-03-172015-03-1918,950— $00SEC↗
AGN ALLERGAN INC D To issuer deriv2015-03-172015-03-1922,300— $00SEC↗
AGN ALLERGAN INC D To issuer deriv2015-03-172015-03-1917,600— $00SEC↗
AGN ALLERGAN INC D To issuer deriv2015-03-172015-03-1919,000— $00SEC↗
AGN ALLERGAN INC D To issuer deriv2015-03-172015-03-1918,000— $00SEC↗
AGN ALLERGAN INC D To issuer2015-03-172015-03-1932,320— $00SEC↗
AGN ALLERGAN INC D To issuer2015-03-172015-03-196,495— $00SEC↗
AGN ALLERGAN INC D To issuer2015-03-172015-03-196,045— $00SEC↗
AGN ALLERGAN INC A Award2015-03-172015-03-1911,274— $032,320SEC↗
AGN ALLERGAN INC G Gift2015-03-162015-03-192,174— $021,047SEC↗
AGN ALLERGAN INC A Award deriv2015-02-202015-02-24511— $0511SEC↗
AGN ALLERGAN INC F Tax w/h2015-02-172015-02-19827$230.15 $190.3K23,221SEC↗
AGN ALLERGAN INC A Award deriv2014-10-292014-10-3111,271— $011,271SEC↗